News

In partnership with The Cancer Imaging Archive (TCIA), the American Association of Physicists in Medicine released a special virtual issue of Medical Physics in March 2021 titled, “Datasets Hosted in NCI’s Cancer Imaging Archive.” This special issue aims to highlight valuable examples of both Medical Physics Data Set Articles (MPDAs) and publicly available data sets that can be reused for future research endeavors and utilized for addressing emerging scientific or clinical questions.

New cancer genomic data sets from the Count Me In, Clinical Proteomic Tumor Analysis Consortium, and Human Cancer Models Initiative projects are now available through NCI’s Genomic Data Commons.

Attending the 2021 American Association for Cancer Research (AACR) Annual Meeting? Here are a few event and poster sessions you won’t want to miss to learn more about the latest NCI data science, data commons, and cancer research activities.

The Pediatric Genomic Data Inventory (PGDI) is now available on datascience.cancer.gov for data scientists and cancer researchers. This resource lists known ongoing and completed sequencing projects of pediatric cancer cohorts from the United States and other countries, along with some basic details and reference metadata.

NCI’s Office of Cancer Genomics’ data analysis and experimental observations tool—CTD² Dashboard—aims to make cancer-relevant results from the CTD² Network easier to use. Learn more about recent improvements to the Dashboard.

The Human Cancer Models Initiative’s (HCMI’s) Searchable Catalog now has new features that allow users to easily locate models and their case-associated data in the Genomic Data Commons.

New pancreatic cancer data sets are now available through the NCI Genomic Data Commons, Proteomic Data Commons, and The Cancer Imaging Archive.

Clinical plasma samples and associated clinical data collected from breast cancer patients by the Clinical Proteomic Tumor Analysis Consortium (CPTAC) are now publicly available research resources.

In collaboration with the National Institute of Allergy and Infectious Diseases and the Center for Disease Control and Prevention, NCI has developed COVID-19 Seroprevalence Hub (COVID-19 SeroHub), a central repository of SARS-CoV-2 seroprevalence studies.

NCI’s Proteomic Data Commons (PDC) has released new data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and supplemental data from the Children’s Brain Tumor Network (CBTN). This release contains 350 gigabytes of open-access proteomic data, including breast, ovarian, and pediatric brain cancer studies.